EMD-14810

Single-particle
4.2 Å
EMD-14810 Deposition: 21/04/2022
Map released: 04/05/2022
Last modified: 28/12/2022
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-14810

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV-2 S 2P trimer in complex with monovalent DARPin R2 (State 1) - Consensus Map

EMD-14810

Single-particle
4.2 Å
EMD-14810 Deposition: 21/04/2022
Map released: 04/05/2022
Last modified: 28/12/2022
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, synthetic construct
Sample: SARS-CoV-2 S 2P trimer in complex with monovalent DARPin R2

Deposition Authors: Hurdiss DL , Drulyte I
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants.
PUBMED: 35864170
DOI: doi:10.1038/s41587-022-01382-3
ISSN: 1087-0156
ASTM: NABIF9
Grant Support: